Pacira Pharmaceuticals buy Barclays PLC
Start price
23.10.23
/
50%
€26.20
Target price
23.10.24
€53.51
Performance (%)
3.05%
Price
30.05.24
€27.80
Summary
This prediction is currently active. With a performance of 3.05%, the BUY prediction by Barclays_PLC for Pacira Pharmaceuticals is trending in the right direction. This prediction currently runs until 23.10.24. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacira Pharmaceuticals | 1.460% | 1.460% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by Barclays_PLC for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Barclays PLC from $60.00 to $57.00. They now have an "overweight" rating on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by Barclays_PLC for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
08.05.24
08.05.24
€35.35
08.05.25
08.05.25
5.22%
30.05.24
30.05.24